NLS Pharma News

Clinical Trials – April 9, 2025

New clinical trial map launched in the EU

A new clinical trial map is now accessible from the public website of the Clinical Trials Information System (CTIS).

Agreement – April 14, 2025

OncoZenge in agreement for BupiZenge in the GCC Region

OncoZenge and Avernus Pharma General Trading, a pharma marketing company from the UAE, have signed an exclusive agreement to license BupiZenge for commercialization and distribution in the Gulf Cooperation Council (GCC) region.

Acquisition – April 10, 2025

EQT to sell Karo Healthcare to KKR

EQT and KKR has announced that EQT VIII fund has agreed to sell Karo Healthcare to KKR.

Collaboration – April 8, 2025

Circio initiate collaboration with Entos Pharmaceuticals

Circio Holding (former Targovax) and Entos Pharmaceuticals have announced the initiation of a research collaboration.

Biotech Business – April 1, 2025

FDA removes clinical hold of Oncopeptides’ OPD5

Oncopeptides has announced the U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on Oncopeptides’ next-gen drug OPD5.

Clinical Trials

Profiles in Pharma

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.